en

Sign up
Investments involve risks and are not suitable for all investors.

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

Home・Stock List・Aclaris Therapeutics Inc
Search

Aclaris Therapeutics Inc

Closed

1.16

Neutral

Price update 10 Oct 2024, 19:49 UTC

BuySell

Overview

Share price change

24h

Current

Min

1.13

Max

1.17

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+70.94 upside

Dividends

By Dow Jones

Next Earnings

4 Nov 2024

Technical Score

By Trading Central

Confidence

Bullish Evidence

1.12 / 1.17 Support & Resistance

Aclaris Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 Jul 2024, 20:04 UTC

Acquisitions, Mergers, Takeovers

Aclaris Therapeutics Received $26.5 M Upfront Plus Is Eligible for Up to $5M in Milestones >ACRS

DJ

Read

16 Jul 2024, 20:03 UTC

Acquisitions, Mergers, Takeovers

Aclaris Sells Portion of Future Royalty Payments and Milestones From Eli Lilly on Sales of OLUMIANT for Alopecia Areata to OMERS

DJ

Read

Peer Comparison

Price change

Aclaris Therapeutics Inc Forecast

Price Target

By TipRanks

70.94% upside

12 Months Forecast

Average 2 USD  70.94%

High 2 USD

Low 2 USD

Based on 3 Wall Street analysts offering 12 month price targets forAclaris Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

3 ratings

0

Buy

3

Hold

0

Sell

Based on 3 analysts giving stock ratings to Aclaris Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

1.12 / 1.17Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Neutral Evidence

The bullish and bearish events are balanced.

Long Term

Strong Bearish Evidence

All events are bearish.

Other stocks from the sector

LLY

Eli Lilly and Co.

911.36

↓-1.01%

UNH

UnitedHealth Group Inc

597.64

↑ +0.96%

NVO

Novo Nordisk A-S

117.53

↑ +0.34%

JNJ

Johnson and Johnson

160.64

↓-0.12%

ABBV

AbbVie Inc

194.4

↓-0.21%